Skip to main content
OpenTrials
Completed

NCT Number: NCT02916030

Vitamin D and Stroke

Stroke remains one of the most devastating neurological diseases, often causing death, or gross physical impairment. It is the second most common cause of death worldwide and a major cause of acquired disability in adults.Vitamin D deficiency has been reported to contribute to the risk of cardiovascular disease especially stroke.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine

Asyut, 74111, Egypt

About this study

This case -control observational prospective study will conducted on fifty patients with first -ever acute onset stroke within seven days (25 patients with hemorrhagic stroke and 25 patients with ischemic stroke )

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Onset is within one week
  • Confirmed stroke by brain CAT and / or MRI scan either haemorrhage or infarction

Exclusion criteria

  • Cognitive and mental changes
  • Recurrent stroke
  • Hepatic and renal impairment
  • Endocrinal diseases
  • Steroid therapy
  • Vitamin D or Ca supplementation
  • Previous fractures
  • Bone diseases
  • brain neoplasm,
  • Autoimmune diseases
  • History of acute and chronic inflammatory diseases
  • Malignancy,
  • Trauma
  • Surgery
  • Acute vascular diseases that occurred within four weeks prior the onset of stroke
  • History myocardial infarction ˂3 months.

Treatment and study plan

Vit D

Dietary Supplement

It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types

Primary outcomes

  1. serum 25 (OH) D levels

    Time frame: Within the first 24 hours

    serum 25 (OH) D levels

Secondary outcomes

  1. Stroke severity

    Time frame: Within the first 24 hours

    Stroke severity will be assessed by Scandinavian Stroke scale Stroke (SSS)

  2. Stroke etiology

    Time frame: Within the first 24 hours

  3. Stroke risk factors

    Time frame: Within the first 24 hours

  4. Stroke subtypes

    Time frame: Within the first 24 hours

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Vitamin D and Stroke: A Comparative Study to Risk Factors and Stroke Type

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 27, 2016
Registry last updated
Jul 13, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.